Krilogy Financial’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Sell
21,072
-39
-0.2% -$1.9K 0.03% 351
2026
Q1
$937K Sell
21,111
-9,791
-32% -$421K 0.03% 392
2025
Q4
$1.35M Buy
30,902
+10,338
+50% +$428K 0.05% 280
2025
Q3
$830K Buy
20,564
+10,215
+99% +$411K 0.03% 382
2025
Q2
$456K Buy
+10,349
New +$414K 0.03% 222
2018
Q4
Sell
-200
Closed -$4K 302
2018
Q3
$4K Buy
+200
New +$3.9K ﹤0.01% 643
2018
Q2
Sell
-200
Closed -$4K 305
2018
Q1
$4K Sell
200
-400
-67% -$11.1K ﹤0.01% 623
2017
Q4
$18K Buy
600
+300
+100% +$7.98K ﹤0.01% 447
2017
Q3
$7K Sell
300
-800
-73% -$21.3K ﹤0.01% 612
2017
Q2
$27K Buy
+1,100
New +$23.3K 0.01% 399

Other funds holding EXEL

Krilogy Financial's EXEL Position: Q2 2026 in Review

Krilogy Financial reduced its Exelixis (EXEL) stake by 0.18% in Q2 2026, selling an estimated $1.9K and leaving 21,072 shares worth $1.15M. The position accounts for 0.03% of the portfolio, ranked #351.

Krilogy Financial first reported a position in EXEL in Q2 2017 and has held it in 10 quarters since. The position peaked at $1.35M in Q4 2025. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Krilogy Financial held 21,072 shares of Exelixis worth $1.15M as of Q2 2026.
  • Krilogy Financial sold 39 Exelixis shares in Q2 2026, an estimated $1.9K.
  • Exelixis made up 0.03% of Krilogy Financial's portfolio in Q2 2026, its #351 holding.
  • Krilogy Financial first reported a position in Exelixis in Q2 2017 and has held it in 10 quarters since.
  • Krilogy Financial's Exelixis position peaked at $1.35M in Q4 2025.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Krilogy Financial's 13F filing for Q2 2026, filed 27 Jul 2026.